Wealthspring Capital’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Wealthspring Capital’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,500	Closed	-$153K	–	504
2022 Q1	$153K	Sell	15,500 -1,000	-6%	-$9.91K	0.03%	404
2021 Q4	$164K	Hold	16,500	–	–	0.04%	358
2021 Q3	$163K	Hold	16,500	–	–	0.04%	292
2021 Q2	$166K	Hold	16,500	–	–	0.04%	276
2021 Q1	$167K	Sell	16,500 -1,000	-6%	-$10.7K	0.05%	275
2020 Q4	$182K	Buy	+17,500	New	+$183K	0.09%	148

Other funds holding FLACU

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Wealthspring Capital's FLACU Position: Q2 2022 in Review

Wealthspring Capital sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2022, closing a stake of 15,500 shares — an estimated $153K sold.

Wealthspring Capital first reported a position in FLACU in Q4 2020 and held it in 6 quarters. The position peaked at $182K in Q4 2020. 17 funds tracked by Wall St. Rank hold FLACU as of Q2 2022.

Wealthspring Capital reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2022 after selling out during the quarter.
Wealthspring Capital sold 15,500 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2022, an estimated $153K.
Wealthspring Capital first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 6 quarters.
Wealthspring Capital's Frazier Lifesciences Acquisition Corporation Unit position peaked at $182K in Q4 2020.
17 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2022.

Based on Wealthspring Capital's 13F filing for Q2 2022, filed 22 Jul 2022.